118 related articles for article (PubMed ID: 38270934)
21. Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide.
Lee GA; Lin WL; Kuo DP; Li YT; Chang YW; Chen YC; Huang SW; Hsu JB; Chen CY
Int J Nanomedicine; 2021; 16():5233-5246. PubMed ID: 34366665
[TBL] [Abstract][Full Text] [Related]
22. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
23. The effect of ligands on FePt-Fe3O4 core-shell magnetic nanoparticles.
Kim DH; Tamada Y; Ono T; Bader SD; Rozhkova EA; Novosad V
J Nanosci Nanotechnol; 2014 Mar; 14(3):2648-52. PubMed ID: 24745278
[TBL] [Abstract][Full Text] [Related]
24. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies.
Iancu SD; Albu C; Chiriac L; Moldovan R; Stefancu A; Moisoiu V; Coman V; Szabo L; Leopold N; Bálint Z
Int J Nanomedicine; 2020; 15():4811-4824. PubMed ID: 32753867
[TBL] [Abstract][Full Text] [Related]
26. Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.
Sharma VK; Alipour A; Soran-Erdem Z; Aykut ZG; Demir HV
Nanoscale; 2015 Jun; 7(23):10519-26. PubMed ID: 26010145
[TBL] [Abstract][Full Text] [Related]
27. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
28. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
[TBL] [Abstract][Full Text] [Related]
29. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
30. A novel synthetic route for high-index faceted iron oxide concave nanocubes with high T
Situ-Loewenstein SF; Wickramasinghe S; Abenojar EC; Erokwu BO; Flask CA; Lee Z; Samia ACS
J Mater Sci Mater Med; 2018 May; 29(5):58. PubMed ID: 29730814
[TBL] [Abstract][Full Text] [Related]
31. Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.
Chaudhary R; Roy K; Kanwar RK; Walder K; Kanwar JR
J Nanobiotechnology; 2016 Jan; 14():6. PubMed ID: 26775253
[TBL] [Abstract][Full Text] [Related]
32. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
[TBL] [Abstract][Full Text] [Related]
33. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
Herman DA; Ferguson P; Cheong S; Hermans IF; Ruck BJ; Allan KM; Prabakar S; Spencer JL; Lendrum CD; Tilley RD
Chem Commun (Camb); 2011 Aug; 47(32):9221-3. PubMed ID: 21761066
[TBL] [Abstract][Full Text] [Related]
34. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
[TBL] [Abstract][Full Text] [Related]
35. Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
Key J; Dhawan D; Cooper CL; Knapp DW; Kim K; Kwon IC; Choi K; Park K; Decuzzi P; Leary JF
Int J Nanomedicine; 2016; 11():4141-55. PubMed ID: 27621615
[TBL] [Abstract][Full Text] [Related]
36. Silica Coated Iron/Iron Oxide Nanoparticles as a Nano-Platform for T
Mathieu P; Coppel Y; Respaud M; Nguyen QT; Boutry S; Laurent S; Stanicki D; Henoumont C; Novio F; Lorenzo J; Montpeyó D; Amiens C
Molecules; 2019 Dec; 24(24):. PubMed ID: 31861222
[TBL] [Abstract][Full Text] [Related]
37. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
38. Magnetic core-shell nanowires as MRI contrast agents for cell tracking.
Martínez-Banderas AI; Aires A; Plaza-García S; Colás L; Moreno JA; Ravasi T; Merzaban JS; Ramos-Cabrer P; Cortajarena AL; Kosel J
J Nanobiotechnology; 2020 Mar; 18(1):42. PubMed ID: 32164746
[TBL] [Abstract][Full Text] [Related]
39. Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r₂ relaxivity for highly sensitive in vivo MRI of tumors.
Lee N; Choi Y; Lee Y; Park M; Moon WK; Choi SH; Hyeon T
Nano Lett; 2012 Jun; 12(6):3127-31. PubMed ID: 22575047
[TBL] [Abstract][Full Text] [Related]
40. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
Tähkä S; Laiho A; Kostiainen MA
Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
